Patents Assigned to Peter E. Nielsen
  • Publication number: 20030176325
    Abstract: The present invention relates to novel drugs which may be used in combating infectious micro-organisms, particularly bacteria.
    Type: Application
    Filed: October 19, 2001
    Publication date: September 18, 2003
    Applicant: Pantheco A/S and Peter E. Nielsen
    Inventors: Peter E. Nielsen, Liam Good, Henrik Frydenlund Hansen, Frederik Beck, Leila Malik, Carsten Schou, Margit Wissenbach, Birgit Kjaeldgaard Giwercman
  • Patent number: 5986053
    Abstract: Peptide nucleic acids and analogues of peptide nucleic acids are used to form duplex, triplex, and other structures with nucleic acids and to modify nucleic acids. The peptide nucleic acids and analogues thereof also are used to modulate protein activity through, for example, transcription arrest, transcription initiation, and site specific cleavage of nucleic acids.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 16, 1999
    Assignees: Isis Pharmaceuticals, Inc., Peter E. Nielsen
    Inventors: David J. Ecker, Ole Buchardt, Michael Egholm, Peter E. Nielsen, Rolf H. Berg, Niels E. Mollegaard
  • Patent number: 5641625
    Abstract: Peptide nucleic acids and analogues of peptide nucleic acids are used to form duplex, triplex, and other structures with nucleic acids and to modify nucleic acids. The peptide nucleic acids and analogues thereof also are used to modulate protein activity through, for example, transcription arrest, transcription initiation, and site specific cleavage of nucleic acids.
    Type: Grant
    Filed: July 2, 1993
    Date of Patent: June 24, 1997
    Assignees: ISIS Pharmaceuticals, Inc., Peter E. Nielsen
    Inventors: David J. Ecker, Ole Buchardt, Michael Egholm, Peter E. Nielsen, Rolf H. Berg, Niels E. Mollegaard